
Mahakailasha Pharmaceuticals Private Limited
About Mahakailasha Pharmaceuticals Private Limited
Data last updated:
Mahakailasha Pharmaceuticals Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 28 May 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U51909UP2019PTC117424. Its GSTIN is 09AAMCM7031Q1ZQ (Uttar Pradesh).
The company has an authorised share capital of ₹50,000 and a paid-up capital of ₹50,000. It is led by directors Devanshu Tripathi and Reshma Dubey.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Bhu Khand No. 5 Kh. No. 558 Hariharpur Hasiyamau, Lucknow, Uttar Pradesh, India – 226002.
As per the financials filed for FY 2024, the company reported a revenue of ₹75.61 Lakh, a growth of 149% compared to the previous year. For the same year it recorded a net profit of ₹40,438 (net margin 0.5%) and EBITDA of ₹50,589 (EBITDA margin 0.7%). Revenue has grown at a compounded annual rate (CAGR) of 47% over three years.
Company details
Contact details
Mahakailasha Pharmaceuticals Private Limited's registered office is in Lucknow, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressBhu Khand No. 5 Kh. No. 558 Hariharpur Hasiyamau, Lucknow, Uttar Pradesh, India – 226002
- IndustryTrading, Specialty, Wholesale
To see the full contact details of Mahakailasha Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Mahakailasha Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Mahakailasha Pharmaceuticals Private Limited, buy the company report.
Financials of Mahakailasha Pharmaceuticals Private Limited
FY 2024 filings availableMahakailasha Pharmaceuticals Private Limited reported revenue of ₹75.61 Lakh (up 149% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 47% over three years, including 149% growth in the latest year. EBITDA rose 914% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹50,589 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹40,438 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.7% | ||||
| Net Profit Margin | 0.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mahakailasha Pharmaceuticals Private Limited, buy the company report.
Board of directors of Mahakailasha Pharmaceuticals Private Limited
Mahakailasha Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Devanshu Tripathi | Director | 28 May 2019 | 7 Years 5 Months | Current |
| Reshma Dubey | Director | 28 May 2019 | 7 Years 5 Months | Current |
Peer comparison
Mahakailasha Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Salsburg Pharmaceuticals Private Limited | ₹76.8 Lakh (FY 2025) | 9.0% | New Delhi, Delhi, India | |||
| Malvyn Pharmaceuticals Private Limited | ₹75.98 Lakh (FY 2024) | -3.0% | Allahabad, Uttar Pradesh, India | |||
| Mahakailasha Pharmaceuticals Private Limitedthis company | ₹75.61 Lakh (FY 2024) | ₹40,438 | 0.5% | 149.0% | Lucknow, Uttar Pradesh, India | |
| Lenax Pharmaceuticals Private Limited | ₹75.07 Lakh (FY 2025) | 62.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Mahakailasha Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Mahakailasha Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mahakailasha Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Mahakailasha Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAMCM7031Q1ZQ | Uttar Pradesh | Active | 19 Jul 2019 |
To see the full GST registrations and return filing status of Mahakailasha Pharmaceuticals Private Limited, buy the company report.
Recent activity
Mahakailasha Pharmaceuticals Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Devanshu Tripathi was appointed as Director on 28 May 2019.
Frequently asked questions
Mahakailasha Pharmaceuticals is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in specialty, within the trading industry. It was incorporated on 28 May 2019 (7+ years old) and is registered under CIN U51909UP2019PTC117424.
Mahakailasha Pharmaceuticals has 2 current directors:
- Devanshu Tripathi - Director
- Reshma Dubey - Director
The latest financial statements of Mahakailasha Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Mahakailasha Pharmaceuticals is 09AAMCM7031Q1ZQ, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Mahakailasha Pharmaceuticals is U51909UP2019PTC117424. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mahakailasha Pharmaceuticals was incorporated on 28 May 2019, making it 7+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Mahakailasha Pharmaceuticals by revenue are Salsburg Pharmaceuticals Private Limited, Malvyn Pharmaceuticals Private Limited, Lenax Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Devanshu Tripathi was appointed as Director on 28 May 2019. Reshma Dubey was appointed as Director on 28 May 2019.
The registered office of Mahakailasha Pharmaceuticals is at Bhu Khand No. 5 Kh. No. 558 Hariharpur Hasiyamau, Lucknow, Uttar Pradesh, India – 226002.
Mahakailasha Pharmaceuticals operates in the trading industry, in the specialty segment.
Mahakailasha Pharmaceuticals can be reached at its registered office: Bhu Khand No. 5 Kh. No. 558 Hariharpur Hasiyamau, Lucknow, Uttar Pradesh, India – 226002.

